Banner MD Anderson Cancer Center at Banner Gateway Medical Center
Gilbert, AZ
Filters
Save & Share
Clear Filters
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Not yet accepting
Lisaftoclax
A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).
Learn more- BCL-2 Inhibitor
- Placebo
- Randomization
- Phase 3
Accepting patients
APG-115
A Phase Ib/II Study of APG-115 Alone or in Combination With Azacitidine in Patients With Relapse/Refractory AML, CMML or MDS
Learn more- MDM2 Inhibitor
- Phase 1/2